PLoS: New Approaches in Filling the Gap in Tuberculosis Drug Discovery

Authors: Martina Casenghi, Stewart T. Cole and Carl F. Nathan

For the first time in decades, there is a TB drug pipeline, but the paucity of candidates is still cause for alarm given the global emergence of drug-resistant TB. In this article, various strategies are explored with a view to stimulating greater research activity.